Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-06-25
DOI
10.1016/j.jaac.2023.04.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Examining Effectiveness and Predictors of Treatment Response of Pivotal Response Treatment in Autism: An Umbrella Review and a Meta-Analysis
- (2022) Mirko Uljarević et al. Frontiers in Psychiatry
- The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
- (2021) Mark R. Libowitz et al. Frontiers in Psychiatry
- Systematic Review and Network Meta-analysis: Second-Generation Antipsychotics in Youth With Bipolar Depression
- (2021) Dr. Melissa P. DelBello et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review
- (2021) Christoph U. Correll et al. World Psychiatry
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Cancer diagnosis and suicide outcomes: Umbrella review and methodological considerations
- (2021) Raffaella Calati et al. JOURNAL OF AFFECTIVE DISORDERS
- Metformin add‐on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial
- (2020) Christoph U. Correll et al. World Psychiatry
- Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects
- (2020) Marco Solmi et al. World Psychiatry
- Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression
- (2020) Marco Pozzi et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Practitioner Review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta‐analysis
- (2020) Rebecca Rodrigues et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Greater Arterial Stiffness in Children with or without Second-generation Antipsychotic Treatment for Mental Health Disorders: Rigidité Artérielle Plus Importante Chez Les Enfants Avec ou Sans Traitement Par Antipsychotiques de la Deuxième Génération Pour des Troubles de Santé Mentale
- (2020) Amanda M. Henderson et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking
- (2019) Chiara Vantaggiato et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Current pharmacotherapy options for conduct disorders in adolescents and children
- (2019) Sohil Khan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI
- (2019) Trude S. Jahr Vedal et al. PSYCHONEUROENDOCRINOLOGY
- Safety and Tolerability of Antipsychotic Medication in Individuals with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
- (2019) Basmah H. Alfageh et al. PEDIATRIC DRUGS
- Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses
- (2019) Miquel A. Fullana et al. PSYCHOLOGICAL MEDICINE
- Effects of antidepressant and antipsychotic use on weight gain: A systematic review
- (2019) Lucia Alonso‐Pedrero et al. Obesity Reviews
- Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
- (2019) Celso Arango et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Differences in Metabolic Factors Between Antipsychotic-Induced Weight Gain and Non-pharmacological Obesity in Youths
- (2018) Simone Pisano et al. CLINICAL DRUG INVESTIGATION
- Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Lurasidone in Children and Adolescents: Systematic Review and Case Report
- (2018) Jonathan Channing et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis
- (2017) Anne Katrine Pagsberg et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
- (2017) Joseph T. Flynn et al. PEDIATRICS
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- (2017) Beverley J Shea et al. BMJ-British Medical Journal
- Erratum to: Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis
- (2016) Cheryl McQuire et al. BMC Psychiatry
- Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients
- (2016) Marco Pozzi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses
- (2016) Vanesa Bellou et al. PARKINSONISM & RELATED DISORDERS
- Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics
- (2016) Britta Galling et al. JAMA Psychiatry
- Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
- (2015) Lazaros Belbasis et al. LANCET NEUROLOGY
- Trends in Mental Health Care among Children and Adolescents
- (2015) Mark Olfson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Pharmacological and Psychological Interventions for the Treatment of Psychosis and Schizophrenia in Children, Adolescents and Young Adults: A Systematic Review and Meta-Analysis
- (2015) Megan R. Stafford et al. PLoS One
- Systematic review finds overlapping reviews were not mentioned in every other overview
- (2014) Dawid Pieper et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Molecular pathophysiology of metabolic effects of antipsychotic medications
- (2014) Jacob S. Ballon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Systematic review of the efficacy and tolerability of Clozapine in the treatment of youth with early onset schizophrenia
- (2013) C. Schneider et al. EUROPEAN PSYCHIATRY
- Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis
- (2013) Noor B. Almandil et al. PEDIATRIC DRUGS
- Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth
- (2013) William V. Bobo et al. JAMA Psychiatry
- Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children
- (2011) Tamara Pringsheim et al. DRUG SAFETY
- Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies
- (2011) Alessandro Zuddas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons
- (2010) David Fraguas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1
- (2008) Jonathan M. Meyer et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More